Université de Lyon, Centre de Recherche en Cancérologie de Lyon, Cancer Cell Plasticity Department, UMR INSERM 1052 CNRS 5286, Centre, Léon Bérard, Lyon, France; Department of chemistry, University of Isfahan, Isfahan, Iran.
Université de Lyon, Centre de Recherche en Cancérologie de Lyon, Cancer Cell Plasticity Department, UMR INSERM 1052 CNRS 5286, Centre, Léon Bérard, Lyon, France.
Nanomedicine. 2019 Oct;21:102060. doi: 10.1016/j.nano.2019.102060. Epub 2019 Jul 20.
G-rich oligonucleotide, AS1411, has been shown to interact with nucleolin and to inhibit cancer cell proliferation and tumor growth. This antiproliferative action is increased when AS1411 is conjugated to different types of nanoparticles. However, the molecular mechanisms are not known. In this work, we show in several cell lines that optimized AS1411-conjugated gold nanoparticles (GNS-AS1411) inhibit nucleolin expression at the RNA and protein levels. We observed an alteration of the nucleolar structure with a decrease of ribosomal RNA accumulation comparable to what is observed upon nucleolin knock down. However, the expression of genes involved in cell cycle and the cell cycle blockage by GNS-AS1411 are not regulated in the same way as that in cells where nucleolin has been knocked down. These data suggest that the anti-proliferative activity of GNS-AS1411 is not the only consequence of nucleolin targeting and down-regulation.
富含 G 的寡核苷酸 AS1411 已被证明与核仁蛋白相互作用,并能抑制癌细胞增殖和肿瘤生长。当 AS1411 与不同类型的纳米颗粒结合时,这种抗增殖作用会增强。然而,其分子机制尚不清楚。在这项工作中,我们在几种细胞系中表明,优化的 AS1411 偶联金纳米颗粒(GNS-AS1411)可在 RNA 和蛋白质水平上抑制核仁蛋白的表达。我们观察到核仁结构发生改变,核糖体 RNA 积累减少,与核仁蛋白敲低时观察到的情况相似。然而,GNS-AS1411 对细胞周期相关基因的表达和细胞周期阻断的调控方式与核仁蛋白敲低的细胞不同。这些数据表明,GNS-AS1411 的抗增殖活性不仅仅是靶向和下调核仁蛋白的结果。